The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

MF Osuchowski, MS Winkler, T Skirecki… - The Lancet …, 2021 - thelancet.com
The zoonotic SARS-CoV-2 virus that causes COVID-19 continues to spread worldwide, with
devastating consequences. While the medical community has gained insight into the …

Co-infections in people with COVID-19: a systematic review and meta-analysis

L Lansbury, B Lim, V Baskaran, WS Lim - Journal of infection, 2020 - Elsevier
Objectives In previous influenza pandemics, bacterial co-infections have been a major
cause of mortality. We aimed to evaluate the burden of co-infections in patients with COVID …

[HTML][HTML] Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study

SA Guler, L Ebner, C Aubry-Beigelman… - European respiratory …, 2021 - Eur Respiratory Soc
Background The infectious coronavirus disease 2019 (COVID-19) pandemic is an ongoing
global healthcare challenge. Up to one-third of hospitalised patients develop severe …

The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications

JD McFadyen, H Stevens, K Peter - Circulation research, 2020 - Am Heart Assoc
The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the ensuing global pandemic has presented a health emergency of unprecedented …

COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City

AC Borczuk, SP Salvatore, SV Seshan, SS Patel… - Modern …, 2020 - nature.com
Abstract SARS-CoV-2, the etiologic agent of COVID-19, is a global pandemic with
substantial mortality dominated by acute respiratory distress syndrome. We systematically …

Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs …

T Menter, JD Haslbauer, R Nienhold, S Savic… - …, 2020 - Wiley Online Library
Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2), has rapidly evolved into a sweeping pandemic. Its major …

Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study

L Carsana, A Sonzogni, A Nasr, RS Rossi… - The Lancet infectious …, 2020 - thelancet.com
Background COVID-19 is characterised by respiratory symptoms, which deteriorate into
respiratory failure in a substantial proportion of cases, requiring intensive care in up to a …

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

D McGonagle, JS O'Donnell, K Sharif… - The Lancet …, 2020 - thelancet.com
The lung pathology seen in patients with coronavirus disease 2019 (COVID-19) shows
marked microvascular thrombosis and haemorrhage linked to extensive alveolar and …

[HTML][HTML] Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer

S Tian, W Hu, L Niu, H Liu, H Xu, SY Xiao - Journal of thoracic oncology, 2020 - Elsevier
There is currently a lack of pathologic data on the novel coronavirus (severe acute
respiratory syndrome coronavirus 2) pneumonia, or coronavirus disease 2019 (COVID-19) …

Respiratory follow-up of patients with COVID-19 pneumonia

PM George, SL Barratt, R Condliffe, SR Desai… - Thorax, 2020 - thorax.bmj.com
The COVID-19 pandemic has led to an unprecedented surge in hospitalised patients with
viral pneumonia. The most severely affected patients are older men, individuals of black and …